Back to Search
Start Over
Medication Co-payment Vouchers, Adherence With Antiplatelet Therapy, and Adverse Cardiovascular Events After Myocardial Infarction.
- Source :
-
JAMA: Journal of the American Medical Association . 1/1/2019, Vol. 321 Issue 1, p37-39. 3p. - Publication Year :
- 2019
-
Abstract
- The article discusses the results of the Affordability and Real-World Antiplatelet Treatment Effectiveness After Myocardial Infarction Study (ARTEMIS), that was published within the issue. Topics covered include the ability of co-payment vouchers for PSY12 inhibitors to reduce major adverse cardiovascular events (MACE), adherence to dual antiplatelet therapy, and the increased use of ticagrelor.
Details
- Language :
- English
- ISSN :
- 00987484
- Volume :
- 321
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- JAMA: Journal of the American Medical Association
- Publication Type :
- Academic Journal
- Accession number :
- 134087455
- Full Text :
- https://doi.org/10.1001/jama.2018.20396